Edwards Lifesciences Corp (EW)
66.48
-1.06
(-1.57%)
USD |
NYSE |
Nov 04, 16:00
66.48
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Enterprise Value: 39.36B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 39.36B |
| October 31, 2024 | 39.04B |
| October 30, 2024 | 40.02B |
| October 29, 2024 | 40.46B |
| October 28, 2024 | 39.95B |
| October 25, 2024 | 40.47B |
| October 24, 2024 | 41.05B |
| October 23, 2024 | 41.21B |
| October 22, 2024 | 40.38B |
| October 21, 2024 | 40.87B |
| October 18, 2024 | 41.01B |
| October 17, 2024 | 39.92B |
| October 16, 2024 | 39.82B |
| October 15, 2024 | 40.18B |
| October 14, 2024 | 40.62B |
| October 11, 2024 | 39.72B |
| October 10, 2024 | 39.79B |
| October 09, 2024 | 39.65B |
| October 08, 2024 | 39.96B |
| October 07, 2024 | 37.55B |
| October 04, 2024 | 38.13B |
| October 03, 2024 | 38.05B |
| October 02, 2024 | 37.92B |
| October 01, 2024 | 37.89B |
| September 30, 2024 | 38.43B |
| Date | Value |
|---|---|
| September 27, 2024 | 38.78B |
| September 26, 2024 | 38.29B |
| September 25, 2024 | 38.08B |
| September 24, 2024 | 38.63B |
| September 23, 2024 | 39.25B |
| September 20, 2024 | 38.93B |
| September 19, 2024 | 39.19B |
| September 18, 2024 | 39.35B |
| September 17, 2024 | 39.17B |
| September 16, 2024 | 40.46B |
| September 13, 2024 | 39.95B |
| September 12, 2024 | 39.72B |
| September 11, 2024 | 39.79B |
| September 10, 2024 | 39.12B |
| September 09, 2024 | 38.26B |
| September 06, 2024 | 38.92B |
| September 05, 2024 | 38.45B |
| September 04, 2024 | 40.20B |
| September 03, 2024 | 40.09B |
| August 30, 2024 | 40.82B |
| August 29, 2024 | 40.91B |
| August 28, 2024 | 40.03B |
| August 27, 2024 | 40.62B |
| August 26, 2024 | 40.09B |
| August 23, 2024 | 41.37B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
31.68B
Minimum
Mar 23 2020
80.39B
Maximum
Dec 30 2021
52.74B
Average
51.05B
Median
Enterprise Value Benchmarks
| Teleflex Inc | 11.32B |
| Becton Dickinson & Co | 82.01B |
| NeuroOne Medical Technologies Corp | 27.34M |
| SINTX Technologies Inc | -1.984M |
| Nutriband Inc | 59.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.071B |
| Revenue (Quarterly) | 1.354B |
| Total Expenses (Quarterly) | 960.10M |
| EPS Diluted (Quarterly) | 5.13 |
| Gross Profit Margin (Quarterly) | 80.59% |
| Profit Margin (Quarterly) | 26.43% |
| Earnings Yield | 10.42% |
| Operating Earnings Yield | 4.08% |
| Normalized Earnings Yield | 3.888 |